Improving the Management of CRS/NP: Selecting the Right Patients for Targeted Treatment
Chair, Stella Lee, MD, discusses chronic rhinosinusitis with nasal polyps in this CME/MOC/CC activity titled “Improving the Management of Chronic Rhinosinusitis With Nasal Polyps: Practical Strategies for Selecting the Right Patients for Targeted Treatment.” For the full presentation, downloadable Practice Aids, slides, and complete CME/MOC/CC information, and to apply for credit, please visit us at PeerView.com/ERM865. CME/MOC/CC credit will be available until February 25, 2022.
Видео Improving the Management of CRS/NP: Selecting the Right Patients for Targeted Treatment канала PeerView CME
Видео Improving the Management of CRS/NP: Selecting the Right Patients for Targeted Treatment канала PeerView CME
Показать
Комментарии отсутствуют
Информация о видео
Другие видео канала
Drs. Chodos & Neel discuss #AlzheimersDisease at #IM2023 - https://bit.ly/41gVwsnNon–Cystic Fibrosis Bronchiectasis: Leveraging Early Diagnosis and Emerging TherapiesPCSK9-Targeting Strategies to Achieve Lipid Goals & Reduce CV Risks in HyperlipidemiaSevere Asthma: Directing New Treatment Approaches at the Airway EpitheliumEpisode 5. State-of-the-Art Treatment: Catching Up With Current GuidelinesStrategies for Improving Outcomes in Hypertrophic CardiomyopathyEpisode 4: How Can We Talk About VTE to Our Patients?Updating Our Cardio-Oncology Skills in the Cancer Immunotherapy Era: Management of Cardiac irAEsApplying Evidence to Practice in Postpartum DepressionWatch Drs. Bar-Or & Oh discuss #MultipleSclerosis updates from #CMSC - https://bit.ly/2024MSYFcRn Modulation in Myasthenia Gravis: Applying the Evidence, Tools, and Patient PerspectivesOvercoming Challenges in the Management of Moderate to Severe ADLeveraging the Power of Anti-CD20 mAbs in Patient-Centric Multiple Sclerosis CareFacilitating Cognitive Assessment in Primary Care for Timely Detection of Alzheimer’s DiseaseNew Developments in Allergic and Inflammatory DiseasesIndividualizing Treatment With GLP-1 RAs to Reduce Cardiovascular Risks in Patients With T2DMTargeted Biologic Therapy for Pediatric and Adult Patients With Moderate to Severe ADHBV Is Primary! Your Role in the "Call to Action" to Eliminate Viral Hepatitis By 2030Clinical Utility of Mucus Plugging and Airway HyperresponsivenessEpisode 6. Is That Realistic? What We’ve Learned About Anticoagulation Therapy Real-World Studies